Anti-androgen treatment of prostatic carcinoma may be a risk factor for development of rheumatoid arthritis

Journal of Rheumatology

Volumn 29, Issue 11, 2002, Pages 2459-2462

  Pope, Janet E ^a   Joneja, Mala ^a   Hong, Paul ^a  

^a ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Hormone treatment; Prostate; Rheumatoid arthritis; Risk factor

Indexed keywords

ANTIANDROGEN; ANTIESTROGEN; ANTINUCLEAR ANTIBODY; CYPROTERONE ACETATE; LEUPRORELIN;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HORMONAL THERAPY; HUMAN; MALE; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROSTATE CARCINOMA; RHEUMATOID ARTHRITIS; RISK FACTOR;

AGED; ANDROGEN ANTAGONISTS; ARTHRITIS, RHEUMATOID; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; TESTOSTERONE;

EID: 0036843991     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Serre H, Simon L, Roques JM. Seropositive rheumatoid polyarthritis associated with a pulmonary hypertrophic osteoarthropathy during metastases of a prostatic cancer. Rev Rhum Mal Osteoartic 1968;35:134-8.
2. Subramonian K, Sundaram SK, MacDonald Hull SP. Carcinoma of the prostate associatated with dermatomyositis. BJU Int 2000;86:401-2.
3. Stevens H, Hickling P, Tyrrell CJ, Hammonds JC. Reiter's syndrome after radiotherapy for prostatic carcinoma. Br J Rheumatol 1986;25:417-8.
4. Van den Bergh L, Vanneste SB, Knockaert DC. Palmar fasciitis and arthritis associated with cancer of the prostate. Acta Clin Belg 1991;46:106-10.
5. Linos A, Worthington JW, O'Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: A study of incidence, prevalence and mortality. Am J Epidemiol 1980;111:87-98.
6. Cooper GS, Yuan Z, Jethva RN, Rimm AA. Determination of county-level prostate carcinoma incidence and detection rates with medicare claims data. Cancer 2001;92:102-9.
7. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
8. Terkeltaub R, Esdaile J, Decary F, Tannenbaum H. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. J Rheumatol 1983;10:418-24.
9. Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: Findings in open-label and randomized placebo-controlled trials. Arthritis Rheum 2000;43:2383-90.
10. Metcalfe W, Boulton-Jones JM. Exacerbation of lupus nephritis in association with leuprorelin injection for uterine leiomyoma. Nephrol Dial Transplant 1997;12:1699-700.
11. Spector TD, Perry LA, Tubb G, Silman AJ, Huskisson EC. Low free testosterone levels in rheumatoid arthritis. Ann Rheum Dis 1988;47:65-8.
12. Cutolo M, Balleari E, Giusti M, Monachesi M, Accardo S. Sex hormone status of male patients with rheumatoid arthritis: Evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum 1988;31:1314-7.
13. Spector TD, Ollier W, Perry LA, Silman AJ, Thompson PW, Edwards A. Free and serum testosterone levels in 276 males: A comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls. Clin Rheumatol 1989;8:37-41.
14. Martens HF, Sheets PK, Tenover JS, Dugowson CE, Bremner WJ, Starkebaum G. Decreased testosterone levels in men with rheumatoid arthritis: Effect of low dose prednisone therapy. J Rheumatol 1994;21:1427-31.
15. Cutolo M, Foppiani L, Prete C, et al. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999;26:282-8.
16. Kanik KS, Chrousos GP, Schumacher HR, Crane ML, Yarboro CH, Wilder RL. Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: Relations with indices of inflammation. J Clin Endocrinol Metab 2000;85:1461-6.
17. Masi AT, Da Silva JA, Cutolo M. Perturbations of hypothalamic-pituitary-gonadal axis and adrenal androgen functions in rheumatoid arthritis. Baillieres Clin Rheumatol 1996;10:295-332.
18. Da Silva JA, Larbre JP, Spector TD, Perry LA, Scott DL, Willoughby DA. Protective effect of androgens against inflammation induced cartilage degradation in male rodents. Ann Rheum Dis 1993;52:285-91.
19. Wilder RL. Adrenal and gonadal steroid hormone deficiency in pathogenesis of rheumatoid arthritis. J Rheumatol 1996;23 Suppl 44:10-2.
20. Deighton CM, Watson MJ, Walker DJ. Sex hormones in postmenopausal HLA-identical rheumatoid arthritis discordant sibling pairs. J Rheumatol 1992;19:1663-7.
21. Heikkila R, Aho K, Heliovaara M, et al. Serum androgen-anabolic hormones and the risk of rheumatoid arthritis. Ann Rheum Dis 1998;57:281-5.
22. Cutolo M, Balleari E, Giusti M, Intra E, Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1-5.
23. Hall GM, Larbre JP, Spector TD, Perry LA, Da Silva JA. A randomized trial of testosterone therapy in males with rheumatoid arthritis. Br J Rheumatol 1996;35:568-73.
24. Castagnetta L, Cutolo M, Granata OM, Di Falco M, Bellavia V, Carruba G. Endocrine end-points in rheumatoid arthritis. Ann NY Acad Sci 1999;876:180-92.
25. Kawasaki T, Ushiyama T, Ueyama H, et al. Polymorphic CAG repeats of the androgen receptor gene and rheumatoid arthritis. Ann Rheum Dis 1999;58:500-2.
26. Yong EL, Lim J, Qi W, Ong V, Mifsud A. Molecular basis of androgen receptor diseases. Ann Med 2000;32:15-22.